Patindol, Francisco T.
HRN: 26-10-33 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/25/2024
10/31/2024
IV
1.5g
Q6h
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes